Loading…

Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline

Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic. Biomarkers are needed to predict prognosis and guide management. We aimed to profile microRNA (miRNA) in ADPKD to gain molecular insight and evaluate biomarker potential. Small-RNA libraries were generated from urine spe...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2014-01, Vol.9 (1), p.e86856-e86856
Main Authors: Ben-Dov, Iddo Z, Tan, Ying-Cai, Morozov, Pavel, Wilson, Patricia D, Rennert, Hanna, Blumenfeld, Jon D, Tuschl, Thomas
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c758t-6b64c6d9c13b78a7336c235a9ad1baf8a8179f0a8723fa8b5f421a3fff0a75813
cites cdi_FETCH-LOGICAL-c758t-6b64c6d9c13b78a7336c235a9ad1baf8a8179f0a8723fa8b5f421a3fff0a75813
container_end_page e86856
container_issue 1
container_start_page e86856
container_title PloS one
container_volume 9
creator Ben-Dov, Iddo Z
Tan, Ying-Cai
Morozov, Pavel
Wilson, Patricia D
Rennert, Hanna
Blumenfeld, Jon D
Tuschl, Thomas
description Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic. Biomarkers are needed to predict prognosis and guide management. We aimed to profile microRNA (miRNA) in ADPKD to gain molecular insight and evaluate biomarker potential. Small-RNA libraries were generated from urine specimens of ADPKD patients (N = 20) and patients with chronic kidney disease of other etiologies (CKD, N = 20). In this report, we describe the miRNA profiles and baseline characteristics. For reference, we also examined the miRNA transcriptome in primary cultures of ADPKD cyst epithelia (N = 10), normal adult tubule (N = 8) and fetal tubule (N = 7) epithelia. In primary cultures of ADPKD kidney cells, miRNA cistrons mir-143(2) (9.2-fold), let-7i(1) (2.3-fold) and mir-3619(1) (12.1-fold) were significantly elevated compared to normal tubule epithelia, whereas mir-1(4) members (19.7-fold), mir-133b(2) (21.1-fold) and mir-205(1) (3.0-fold) were downregulated (P
doi_str_mv 10.1371/journal.pone.0086856
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1492542302</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478835619</galeid><doaj_id>oai_doaj_org_article_9f2f6c7a7886467dbeec79edabec921f</doaj_id><sourcerecordid>A478835619</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758t-6b64c6d9c13b78a7336c235a9ad1baf8a8179f0a8723fa8b5f421a3fff0a75813</originalsourceid><addsrcrecordid>eNqNk81u1DAQxyMEomXhDRBYQkJw2CWOEyfhgLSq-FipolKhXK2JY-96642DnSD2IXhnJt202qAeUA6JJ7_5z4dnoug5jReU5fTd1vW-AbtoXaMWcVzwIuMPolNasmTOk5g9PPo-iZ6EsI3jjBWcP45OkjQtyrzMTqM_V940iuyM9O7y65JAIK3rVNMZsKQybgf-WvlAnCbQdy6gwZLa7UwDTYeo3ct96Iwk16Zu1J7UJigIirTerb0KwbjmPalVkN60HR4GoZ0ZIiGhjVWBQEcqdLGYx9PokQYb1LPxPYuuPn38fvZlfn7xeXW2PJ_LPCu6Oa94KnldSsqqvICcMS4TlkEJNa1AF1DQvNQxFHnCNBRVptOEAtMabShA2Sx6edBtrQti7GQQNC2TLE1YnCCxOhC1g61ovcFG7IUDI24Mzq8FeKzbKlHqRHOZQ14UPOV5XSkl81LVUClZJlSj1ocxWl_tVC2xux7sRHT6pzEbsXa_BCtjTmmMAm9GAe9-9ip0YmeCVNZCo1x_k3eKSed8yPvVP-j91Y3UGrAA02iHceUgKpYp1sEyjrMzixb3UPjUCucFx264v6nD24kDMp363a2hD0Gsvl3-P3vxY8q-PmI3Cmy3Cc72w0CFKZgeQJzmELzSd02msRi25rYbYtgaMW4Nur04vqA7p9s1YX8B3h8V3g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1492542302</pqid></control><display><type>article</type><title>Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central Free</source><creator>Ben-Dov, Iddo Z ; Tan, Ying-Cai ; Morozov, Pavel ; Wilson, Patricia D ; Rennert, Hanna ; Blumenfeld, Jon D ; Tuschl, Thomas</creator><contributor>Long, David</contributor><creatorcontrib>Ben-Dov, Iddo Z ; Tan, Ying-Cai ; Morozov, Pavel ; Wilson, Patricia D ; Rennert, Hanna ; Blumenfeld, Jon D ; Tuschl, Thomas ; Long, David</creatorcontrib><description>Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic. Biomarkers are needed to predict prognosis and guide management. We aimed to profile microRNA (miRNA) in ADPKD to gain molecular insight and evaluate biomarker potential. Small-RNA libraries were generated from urine specimens of ADPKD patients (N = 20) and patients with chronic kidney disease of other etiologies (CKD, N = 20). In this report, we describe the miRNA profiles and baseline characteristics. For reference, we also examined the miRNA transcriptome in primary cultures of ADPKD cyst epithelia (N = 10), normal adult tubule (N = 8) and fetal tubule (N = 7) epithelia. In primary cultures of ADPKD kidney cells, miRNA cistrons mir-143(2) (9.2-fold), let-7i(1) (2.3-fold) and mir-3619(1) (12.1-fold) were significantly elevated compared to normal tubule epithelia, whereas mir-1(4) members (19.7-fold), mir-133b(2) (21.1-fold) and mir-205(1) (3.0-fold) were downregulated (P&lt;0.01). Expression of the dysregulated miRNA in fetal tubule epithelia resembled ADPKD better than normal adult cells, except let-7i, which was lower in fetal cells. In patient biofluid specimens, mir-143(2) members were 2.9-fold higher in urine cells from ADPKD compared to other CKD patients, while expression levels of mir-133b(2) (4.9-fold) and mir-1(4) (4.4-fold) were lower in ADPKD. We also noted increased abundance mir-223(1) (5.6-fold), mir-199a(3) (1.4-fold) and mir-199b(1) (1.8-fold) (P&lt;0.01) in ADPKD urine cells. In ADPKD urine microvesicles, miR-1(2) (7.2-fold) and miR-133a(2) (11.8-fold) were less abundant compared to other CKD patients (P&lt;0.01). We found that in ADPKD urine specimens, miRNA previously implicated as kidney tumor suppressors (miR-1 and miR-133), as well as miRNA of presumed inflammatory and fibroblast cell origin (miR-223/miR-199), are dysregulated when compared to other CKD patients. Concordant with findings in the primary tubule epithelial cell model, this suggests roles for dysregulated miRNA in ADPKD pathogenesis and potential use as biomarkers. We intend to assess prognostic potential of miRNA in a followup analysis.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0086856</identifier><identifier>PMID: 24489795</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Aged ; Analysis ; Biological markers ; Biology ; Biomarkers ; Biomarkers - urine ; Cancer ; Cell culture ; Chronic kidney failure ; Cistrons ; Cysts ; Development and progression ; Disease Progression ; Epigenesis, Genetic ; Epithelial cells ; Etiology ; Female ; Fetus ; Fetuses ; Gene expression ; Gene Library ; High-Throughput Nucleotide Sequencing ; Hospitals ; Humans ; Inflammation ; Kidney diseases ; Kidney transplantation ; Kidney Tubules - metabolism ; Kidney Tubules - pathology ; Laboratories ; Male ; Medical research ; Medicine ; MicroRNA ; MicroRNAs ; MicroRNAs - genetics ; MicroRNAs - urine ; Middle Aged ; miRNA ; Molecular biology ; Nephrology ; Pathogenesis ; Pathology ; Patients ; Polycystic kidney ; Polycystic kidney disease ; Polycystic Kidney, Autosomal Dominant - diagnosis ; Polycystic Kidney, Autosomal Dominant - genetics ; Polycystic Kidney, Autosomal Dominant - pathology ; Polycystic Kidney, Autosomal Dominant - urine ; Primary Cell Culture ; Prognosis ; Proteins ; Regulation ; Ribonucleic acid ; RNA ; RNA polymerase ; Suppressors ; Urine ; Urothelium - metabolism ; Urothelium - pathology</subject><ispartof>PloS one, 2014-01, Vol.9 (1), p.e86856-e86856</ispartof><rights>COPYRIGHT 2014 Public Library of Science</rights><rights>2014 Ben-Dov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2014 Ben-Dov et al 2014 Ben-Dov et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c758t-6b64c6d9c13b78a7336c235a9ad1baf8a8179f0a8723fa8b5f421a3fff0a75813</citedby><cites>FETCH-LOGICAL-c758t-6b64c6d9c13b78a7336c235a9ad1baf8a8179f0a8723fa8b5f421a3fff0a75813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1492542302/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1492542302?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24489795$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Long, David</contributor><creatorcontrib>Ben-Dov, Iddo Z</creatorcontrib><creatorcontrib>Tan, Ying-Cai</creatorcontrib><creatorcontrib>Morozov, Pavel</creatorcontrib><creatorcontrib>Wilson, Patricia D</creatorcontrib><creatorcontrib>Rennert, Hanna</creatorcontrib><creatorcontrib>Blumenfeld, Jon D</creatorcontrib><creatorcontrib>Tuschl, Thomas</creatorcontrib><title>Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic. Biomarkers are needed to predict prognosis and guide management. We aimed to profile microRNA (miRNA) in ADPKD to gain molecular insight and evaluate biomarker potential. Small-RNA libraries were generated from urine specimens of ADPKD patients (N = 20) and patients with chronic kidney disease of other etiologies (CKD, N = 20). In this report, we describe the miRNA profiles and baseline characteristics. For reference, we also examined the miRNA transcriptome in primary cultures of ADPKD cyst epithelia (N = 10), normal adult tubule (N = 8) and fetal tubule (N = 7) epithelia. In primary cultures of ADPKD kidney cells, miRNA cistrons mir-143(2) (9.2-fold), let-7i(1) (2.3-fold) and mir-3619(1) (12.1-fold) were significantly elevated compared to normal tubule epithelia, whereas mir-1(4) members (19.7-fold), mir-133b(2) (21.1-fold) and mir-205(1) (3.0-fold) were downregulated (P&lt;0.01). Expression of the dysregulated miRNA in fetal tubule epithelia resembled ADPKD better than normal adult cells, except let-7i, which was lower in fetal cells. In patient biofluid specimens, mir-143(2) members were 2.9-fold higher in urine cells from ADPKD compared to other CKD patients, while expression levels of mir-133b(2) (4.9-fold) and mir-1(4) (4.4-fold) were lower in ADPKD. We also noted increased abundance mir-223(1) (5.6-fold), mir-199a(3) (1.4-fold) and mir-199b(1) (1.8-fold) (P&lt;0.01) in ADPKD urine cells. In ADPKD urine microvesicles, miR-1(2) (7.2-fold) and miR-133a(2) (11.8-fold) were less abundant compared to other CKD patients (P&lt;0.01). We found that in ADPKD urine specimens, miRNA previously implicated as kidney tumor suppressors (miR-1 and miR-133), as well as miRNA of presumed inflammatory and fibroblast cell origin (miR-223/miR-199), are dysregulated when compared to other CKD patients. Concordant with findings in the primary tubule epithelial cell model, this suggests roles for dysregulated miRNA in ADPKD pathogenesis and potential use as biomarkers. We intend to assess prognostic potential of miRNA in a followup analysis.</description><subject>Adult</subject><subject>Aged</subject><subject>Analysis</subject><subject>Biological markers</subject><subject>Biology</subject><subject>Biomarkers</subject><subject>Biomarkers - urine</subject><subject>Cancer</subject><subject>Cell culture</subject><subject>Chronic kidney failure</subject><subject>Cistrons</subject><subject>Cysts</subject><subject>Development and progression</subject><subject>Disease Progression</subject><subject>Epigenesis, Genetic</subject><subject>Epithelial cells</subject><subject>Etiology</subject><subject>Female</subject><subject>Fetus</subject><subject>Fetuses</subject><subject>Gene expression</subject><subject>Gene Library</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Kidney diseases</subject><subject>Kidney transplantation</subject><subject>Kidney Tubules - metabolism</subject><subject>Kidney Tubules - pathology</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - urine</subject><subject>Middle Aged</subject><subject>miRNA</subject><subject>Molecular biology</subject><subject>Nephrology</subject><subject>Pathogenesis</subject><subject>Pathology</subject><subject>Patients</subject><subject>Polycystic kidney</subject><subject>Polycystic kidney disease</subject><subject>Polycystic Kidney, Autosomal Dominant - diagnosis</subject><subject>Polycystic Kidney, Autosomal Dominant - genetics</subject><subject>Polycystic Kidney, Autosomal Dominant - pathology</subject><subject>Polycystic Kidney, Autosomal Dominant - urine</subject><subject>Primary Cell Culture</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>Regulation</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA polymerase</subject><subject>Suppressors</subject><subject>Urine</subject><subject>Urothelium - metabolism</subject><subject>Urothelium - pathology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk81u1DAQxyMEomXhDRBYQkJw2CWOEyfhgLSq-FipolKhXK2JY-96642DnSD2IXhnJt202qAeUA6JJ7_5z4dnoug5jReU5fTd1vW-AbtoXaMWcVzwIuMPolNasmTOk5g9PPo-iZ6EsI3jjBWcP45OkjQtyrzMTqM_V940iuyM9O7y65JAIK3rVNMZsKQybgf-WvlAnCbQdy6gwZLa7UwDTYeo3ct96Iwk16Zu1J7UJigIirTerb0KwbjmPalVkN60HR4GoZ0ZIiGhjVWBQEcqdLGYx9PokQYb1LPxPYuuPn38fvZlfn7xeXW2PJ_LPCu6Oa94KnldSsqqvICcMS4TlkEJNa1AF1DQvNQxFHnCNBRVptOEAtMabShA2Sx6edBtrQti7GQQNC2TLE1YnCCxOhC1g61ovcFG7IUDI24Mzq8FeKzbKlHqRHOZQ14UPOV5XSkl81LVUClZJlSj1ocxWl_tVC2xux7sRHT6pzEbsXa_BCtjTmmMAm9GAe9-9ip0YmeCVNZCo1x_k3eKSed8yPvVP-j91Y3UGrAA02iHceUgKpYp1sEyjrMzixb3UPjUCucFx264v6nD24kDMp363a2hD0Gsvl3-P3vxY8q-PmI3Cmy3Cc72w0CFKZgeQJzmELzSd02msRi25rYbYtgaMW4Nur04vqA7p9s1YX8B3h8V3g</recordid><startdate>20140129</startdate><enddate>20140129</enddate><creator>Ben-Dov, Iddo Z</creator><creator>Tan, Ying-Cai</creator><creator>Morozov, Pavel</creator><creator>Wilson, Patricia D</creator><creator>Rennert, Hanna</creator><creator>Blumenfeld, Jon D</creator><creator>Tuschl, Thomas</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140129</creationdate><title>Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline</title><author>Ben-Dov, Iddo Z ; Tan, Ying-Cai ; Morozov, Pavel ; Wilson, Patricia D ; Rennert, Hanna ; Blumenfeld, Jon D ; Tuschl, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758t-6b64c6d9c13b78a7336c235a9ad1baf8a8179f0a8723fa8b5f421a3fff0a75813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analysis</topic><topic>Biological markers</topic><topic>Biology</topic><topic>Biomarkers</topic><topic>Biomarkers - urine</topic><topic>Cancer</topic><topic>Cell culture</topic><topic>Chronic kidney failure</topic><topic>Cistrons</topic><topic>Cysts</topic><topic>Development and progression</topic><topic>Disease Progression</topic><topic>Epigenesis, Genetic</topic><topic>Epithelial cells</topic><topic>Etiology</topic><topic>Female</topic><topic>Fetus</topic><topic>Fetuses</topic><topic>Gene expression</topic><topic>Gene Library</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Kidney diseases</topic><topic>Kidney transplantation</topic><topic>Kidney Tubules - metabolism</topic><topic>Kidney Tubules - pathology</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - urine</topic><topic>Middle Aged</topic><topic>miRNA</topic><topic>Molecular biology</topic><topic>Nephrology</topic><topic>Pathogenesis</topic><topic>Pathology</topic><topic>Patients</topic><topic>Polycystic kidney</topic><topic>Polycystic kidney disease</topic><topic>Polycystic Kidney, Autosomal Dominant - diagnosis</topic><topic>Polycystic Kidney, Autosomal Dominant - genetics</topic><topic>Polycystic Kidney, Autosomal Dominant - pathology</topic><topic>Polycystic Kidney, Autosomal Dominant - urine</topic><topic>Primary Cell Culture</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>Regulation</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA polymerase</topic><topic>Suppressors</topic><topic>Urine</topic><topic>Urothelium - metabolism</topic><topic>Urothelium - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ben-Dov, Iddo Z</creatorcontrib><creatorcontrib>Tan, Ying-Cai</creatorcontrib><creatorcontrib>Morozov, Pavel</creatorcontrib><creatorcontrib>Wilson, Patricia D</creatorcontrib><creatorcontrib>Rennert, Hanna</creatorcontrib><creatorcontrib>Blumenfeld, Jon D</creatorcontrib><creatorcontrib>Tuschl, Thomas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ben-Dov, Iddo Z</au><au>Tan, Ying-Cai</au><au>Morozov, Pavel</au><au>Wilson, Patricia D</au><au>Rennert, Hanna</au><au>Blumenfeld, Jon D</au><au>Tuschl, Thomas</au><au>Long, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2014-01-29</date><risdate>2014</risdate><volume>9</volume><issue>1</issue><spage>e86856</spage><epage>e86856</epage><pages>e86856-e86856</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic. Biomarkers are needed to predict prognosis and guide management. We aimed to profile microRNA (miRNA) in ADPKD to gain molecular insight and evaluate biomarker potential. Small-RNA libraries were generated from urine specimens of ADPKD patients (N = 20) and patients with chronic kidney disease of other etiologies (CKD, N = 20). In this report, we describe the miRNA profiles and baseline characteristics. For reference, we also examined the miRNA transcriptome in primary cultures of ADPKD cyst epithelia (N = 10), normal adult tubule (N = 8) and fetal tubule (N = 7) epithelia. In primary cultures of ADPKD kidney cells, miRNA cistrons mir-143(2) (9.2-fold), let-7i(1) (2.3-fold) and mir-3619(1) (12.1-fold) were significantly elevated compared to normal tubule epithelia, whereas mir-1(4) members (19.7-fold), mir-133b(2) (21.1-fold) and mir-205(1) (3.0-fold) were downregulated (P&lt;0.01). Expression of the dysregulated miRNA in fetal tubule epithelia resembled ADPKD better than normal adult cells, except let-7i, which was lower in fetal cells. In patient biofluid specimens, mir-143(2) members were 2.9-fold higher in urine cells from ADPKD compared to other CKD patients, while expression levels of mir-133b(2) (4.9-fold) and mir-1(4) (4.4-fold) were lower in ADPKD. We also noted increased abundance mir-223(1) (5.6-fold), mir-199a(3) (1.4-fold) and mir-199b(1) (1.8-fold) (P&lt;0.01) in ADPKD urine cells. In ADPKD urine microvesicles, miR-1(2) (7.2-fold) and miR-133a(2) (11.8-fold) were less abundant compared to other CKD patients (P&lt;0.01). We found that in ADPKD urine specimens, miRNA previously implicated as kidney tumor suppressors (miR-1 and miR-133), as well as miRNA of presumed inflammatory and fibroblast cell origin (miR-223/miR-199), are dysregulated when compared to other CKD patients. Concordant with findings in the primary tubule epithelial cell model, this suggests roles for dysregulated miRNA in ADPKD pathogenesis and potential use as biomarkers. We intend to assess prognostic potential of miRNA in a followup analysis.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24489795</pmid><doi>10.1371/journal.pone.0086856</doi><tpages>e86856</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2014-01, Vol.9 (1), p.e86856-e86856
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1492542302
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central Free
subjects Adult
Aged
Analysis
Biological markers
Biology
Biomarkers
Biomarkers - urine
Cancer
Cell culture
Chronic kidney failure
Cistrons
Cysts
Development and progression
Disease Progression
Epigenesis, Genetic
Epithelial cells
Etiology
Female
Fetus
Fetuses
Gene expression
Gene Library
High-Throughput Nucleotide Sequencing
Hospitals
Humans
Inflammation
Kidney diseases
Kidney transplantation
Kidney Tubules - metabolism
Kidney Tubules - pathology
Laboratories
Male
Medical research
Medicine
MicroRNA
MicroRNAs
MicroRNAs - genetics
MicroRNAs - urine
Middle Aged
miRNA
Molecular biology
Nephrology
Pathogenesis
Pathology
Patients
Polycystic kidney
Polycystic kidney disease
Polycystic Kidney, Autosomal Dominant - diagnosis
Polycystic Kidney, Autosomal Dominant - genetics
Polycystic Kidney, Autosomal Dominant - pathology
Polycystic Kidney, Autosomal Dominant - urine
Primary Cell Culture
Prognosis
Proteins
Regulation
Ribonucleic acid
RNA
RNA polymerase
Suppressors
Urine
Urothelium - metabolism
Urothelium - pathology
title Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A04%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urine%20microRNA%20as%20potential%20biomarkers%20of%20autosomal%20dominant%20polycystic%20kidney%20disease%20progression:%20description%20of%20miRNA%20profiles%20at%20baseline&rft.jtitle=PloS%20one&rft.au=Ben-Dov,%20Iddo%20Z&rft.date=2014-01-29&rft.volume=9&rft.issue=1&rft.spage=e86856&rft.epage=e86856&rft.pages=e86856-e86856&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0086856&rft_dat=%3Cgale_plos_%3EA478835619%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c758t-6b64c6d9c13b78a7336c235a9ad1baf8a8179f0a8723fa8b5f421a3fff0a75813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1492542302&rft_id=info:pmid/24489795&rft_galeid=A478835619&rfr_iscdi=true